Although atopic dermatitis (AD) is common in childhood, information on the impact of the disease on the family is lacking. To fill this gap, a cross-sectional, web-based survey of children aged 6 months to <18 years was conducted in 18 countries in 5 regions [1]. Parents were invited to participate without knowledge of the survey topic. To be considered as having AD, the patients should meet the following 3 criteria: (i) ever had an itchy rash that was coming and going for at least 6 months; (ii) had this rash at any time in the past 12 months; and (iii) the rash was noted on the fold of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the neck, ears, or eyes. In addition, there had to be a physician diagnosis of eczema with or without skin allergies. Children were stratified as having clear/mild, moderate, or severe AD based on patient’s global assessment in the past week. Parents reported on the impact of living with a child with AD on their family quality of life (QoL) in the past week using the Dermatitis Family Impact (DFI) questionnaire (0–5, normal; 6–10, low impact; 11–20, moderate impact; >20, high impact), time spent taking care of their child due to AD in the past week, and time missed from work for AD-related issues in the past 4 weeks.
Data was analysed of 7,465 children with diagnosed AD (clear/mild 59.0%; moderate 35.9%; severe 4.9%). There were increasing scores of DFI assessed on a scale of 0 (no impact) to 30 (highest impact) with increasing AD severity in all countries. In addition, time spent on care and the need to take time off work increased in parallel with AD severity in all countries (see Figure). All domains of family life were considerably disrupted including everyday-life activities, social activities, sleep, and emotional and financial domains. The survey highlights that childhood AD negatively impacts quality of life of the patient’s family and their caregivers, with the burden generally increasing with AD severity.
Figure: Time spent on care in dependence of AD severity in participating countries [1]
- Barbarot S, et al. Worldwide survey shows that atopic dermatitis in children is associated with a negative impact on their families. Poster 27473, AAD VMX 2021, 23-25 April.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« IL-17 inhibitor effective in axial manifestations of psoriatic arthritis Next Article
Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis »
« IL-17 inhibitor effective in axial manifestations of psoriatic arthritis Next Article
Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis »
Table of Contents: AAD 2021
Featured articles
Letter from the Editor
Late-Breaking Abstracts
Small molecule effective in moderate-to-severe psoriasis
Bruton’s tyrosine kinase inhibition promising for pemphigus vulgaris
Bimekizumab superior to secukinumab in psoriasis
Etrasimod – a new mode of action for treatment of atopic dermatitis
Women at higher risk for dermatologic side effects during immunotherapy
Novel easy-to-use foam formulation clears scalp psoriasis in one-third of patients
Anti-cholinergic gel demonstrates superior long-term tolerability and efficacy in axillary hyperhidrosis
Psoriasis – The Beat Goes On
Psoriasis: The treatment armamentarium continues to grow
Psoriasis management in times of COVID-19: the knowledge is growing steadily
Lower burden of high-risk atherosclerotic plaques in psoriasis patients treated with biologics
COVID-19: What Dermatologists Need to Know
Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on
COVID-19 in children – cutaneous involvement is common
Cutaneous reactions after COVID-19 vaccination: an update
Novel Developments in Sun Protection
Sunless tanning and other developments in sun protection
What Is Hot in Atopic Dermatitis
Comorbidity is common in adult and paediatric atopic dermatitis patients
Significant improvements in the system armamentarium for AD treatment
Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis
Hairy Matters – What Is New in Alopecia
Allergies: an underrated factor in alopecia pathogenesis
Botulinum toxin A: a contradictory role in hair loss
Platelet-rich plasma in androgenetic alopecia – hype or hope?
Acne – New Developments
New therapeutic options add value to current acne treatment
Nicotinamide and probiotics can support acne therapy
Pearls of the Posters
Related Articles
November 5, 2022
AI machine learning algorithm useful in early detection of PsA
July 17, 2024
The unfavourable role of obesity in psoriatic disease
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com